180 related articles for article (PubMed ID: 35793779)
1. Clostridium species diversity in gut microbiota of patients with renal failure.
Khiabani SA; Haghighat S; Khosroshahi HT; Asgharzadeh M; Kafil HS
Microb Pathog; 2022 Aug; 169():105667. PubMed ID: 35793779
[TBL] [Abstract][Full Text] [Related]
2. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
3.
Hanifi GR; Samadi Kafil H; Tayebi Khosroshahi H; Shapouri R; Asgharzadeh M
Arch Razi Inst; 2021; 76(3):521-528. PubMed ID: 34824745
[No Abstract] [Full Text] [Related]
4. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
5. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects].
Guirong YE; Minjie Z; Lixin YU; Junsheng YE; Lin Y; Lisha S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1401-1408. PubMed ID: 30613005
[TBL] [Abstract][Full Text] [Related]
6. [Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors].
Bao WH; Tang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):124-132. PubMed ID: 36718700
[TBL] [Abstract][Full Text] [Related]
7. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
8. Diversity of
Amini Khiabani S; Haghighat S; Tayebi Khosroshahi H; Asgharzadeh M; Samadi Kafil H
Health Promot Perspect; 2023; 13(3):237-242. PubMed ID: 37808937
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.
Yang X; Cai S; Gong J; Zhang J; Lian M; Chen R; Zhou L; Bai P; Liu B; Zhuang M; Tan H; Xu J; Li M
Int Urol Nephrol; 2024 May; 56(5):1751-1762. PubMed ID: 38085410
[TBL] [Abstract][Full Text] [Related]
10. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.
Hu J; Zhong X; Yan J; Zhou D; Qin D; Xiao X; Zheng Y; Liu Y
BMC Nephrol; 2020 Jan; 21(1):12. PubMed ID: 31931722
[TBL] [Abstract][Full Text] [Related]
11. Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China.
Dong D; Ni Q; Wang C; Zhang L; Li Z; Jiang C; EnqiangMao ; Peng Y
BMC Infect Dis; 2018 May; 18(1):207. PubMed ID: 29724187
[TBL] [Abstract][Full Text] [Related]
12. Alterations of gut microbes and their correlation with clinical features in middle and end-stages chronic kidney disease.
Chen H; Wang J; Ouyang Q; Peng X; Yu Z; Wang J; Huang J
Front Cell Infect Microbiol; 2023; 13():1105366. PubMed ID: 37033494
[TBL] [Abstract][Full Text] [Related]
13. Changes in the Intestinal Microbiota in Patients with Stage 5 Chronic Kidney Disease on a Low-Protein Diet and the Effects of Human to Rat Fecal Microbiota Transplantation.
Jiang S; Wang B; Sha T; Li X
Med Sci Monit; 2020 Jun; 26():e921557. PubMed ID: 32592577
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
15. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.
Luo D; Zhao W; Lin Z; Wu J; Lin H; Li Y; Song J; Zhang J; Peng H
Front Cell Infect Microbiol; 2021; 11():579386. PubMed ID: 33834002
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the fecal microbiota of infants with botulism.
Shirey TB; Dykes JK; Lúquez C; Maslanka SE; Raphael BH
Microbiome; 2015 Nov; 3():54. PubMed ID: 26593441
[TBL] [Abstract][Full Text] [Related]
17. Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data.
Zhang Y; Zhong W; Liu W; Wang X; Lin G; Lin J; Fang J; Mou X; Jiang S; Huang J; Zhao W; Zheng Z
Front Cell Infect Microbiol; 2024; 14():1363276. PubMed ID: 38707511
[TBL] [Abstract][Full Text] [Related]
18. Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
Kikuchi M; Ueno M; Itoh Y; Suda W; Hattori M
Nephron; 2017; 135(1):51-60. PubMed ID: 27701177
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Gut Microbiota and Fecal Metabolites in Rats after Prednisone Treatment.
Zhang J; Feng D; Law HK; Wu Y; Zhu GH; Huang WY; Kang Y
Microbiol Spectr; 2021 Dec; 9(3):e0065021. PubMed ID: 34756061
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of Gut Microbiota in Patients with Chronic Kidney Disease.
Yasuno T; Takahashi K; Tada K; Hiyamuta H; Watanabe M; Ito K; Arima H; Masutani K
Intern Med; 2024 Feb; 63(3):347-352. PubMed ID: 37344438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
